ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2586

Cardiac Magnetic Resonance Imaging Reveals Myocardial Damage in Patients with Active Rheumatoid Arthritis

Miia Holmström1, Riitta Koivuniemi2, Tarja Tiippana-Kinnunen2, Antti Kuuliala3, Marjatta Leirisalo-Repo2 and Sari Kivistö1, 1Radiology, HUS Medical Imaging Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland, 2Rheumatology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland, 3Bacteriology and Immunology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Heart disease, magnetic resonance imaging (MRI) and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster Session III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

In rheumatoid arthritis (RA), cardiac involvement is common and frequently subclinical. We used cardiac MRI to identify myocardial abnormalities in patients with active RA, free of symptoms and signs of cardiac disease.

Methods:

Sixty female patients with active RA under age of 70 years (31 patients with early RA awaiting the start of treatment with conventional DMARDs and 29 patients with chronic RA awaiting the start of treatment with biological therapy) and 21 sex and age-matched control subjects (10 patients with FM and 11 healthy volunteers) underwent either 1.5T or 3T cardiac MRI for analyses of T1 relaxation times, late gadolinium enhancement (LGE),  volumes and function of both ventricles.

Table 1. Clinical features of RA patients

Early RA

Chronic RA

p-value

Age, years; mean ± SD

48 ± 15

48 ± 14

0.57

RF positivity; n (%)

26  (84)

23 (85)

1.000

ACPA positivity; n   (%)

27 (87)

26 (93)

0.673

CRP; mean   + SD

16 +  26

7 + 7

0.076

Number of swollen joints; median   (IQR)*

8 (4-10)

6 (2-7)

0.037

Number of tender joints; median   (IQR)*

7 (3-12)

6 (2-11)

0.726

DAS28-CRP; mean ± SD

3.7 ± 1.05

3.4 ± 1.15

0.267

Extra-articular manifestations; n (%)

5 (16)

14 (48)

0.007

Erosions on radiographs; n (%)

5 (17)

23 (85)

<0.001

Duration of symptoms,   years; median (IQR)

0.4 (0.3-0.8)

13.0 (4-26)

<0.001

BMI, kg/m2;   mean ± SD

23.7 ± 4.1

25.5 ± 3.6

0.069

* 66/68 joints evaluated

Results:

By using 1.5T cardiac MRI, native left ventricular (LV) septal T1 time averaged 1010 ± 45 ms in 20 RA patients v.s. 977 ± 18 ms in 11 controls (p = 0.045). With 3T cardiac MRI, the T1 time measured 1170 ± 33 ms in 29 RA patients v.s. 1047 ± 113 ms in 9 controls (p = 0.002). Myocardial LGE was detected in 55% of RA patients, but in none of FM controls. Increased likelihood of LGE was associated with increasing DAS28-CRP (OR 1.87, 95% CI 1.05 to 3.35, p=0.035) and increasing age (OR 1.05, 95% CI 1.00 to 1.09, p=0.040) in multivariate logistic regression model, but not with disease duration or ACPA positivity. Compared with controls, RA patients had impairments in systolic and diastolic function of both ventricles (Table 2). In patients with early RA, right ventricular (RV) dysfunction was more obvious (Table 3).

Table 2. Cardiac MRI findings in RA patients and controls

Variable

RA patients = 60

Mean ± SD

Median (IQR)

 

Controls together =   21

Mean ± SD

Median (IQR)

 p-value

LVEF, %

58.9 ± 4.3

66.7 ± 6.8

<0.001

LVEDV-index, ml/m2

82.3 ± 11.6

75.1 ± 11.0

0.022

LVESV-index, ml/m2

34 (30-40)

25 (21-29)

<0.001

LVSV-index, ml/m2

47 ± 11

43 ± 6

0.24

LVPFR/EDV, 1/s

2.95 ± 0.85

3.44 ± 0.70

0.012

LV mass-index, g/m2

51.3 ± 7.6

53.1 ± 7.2

0.29

RVEF, %

59 ± 6

58 ± 6

0.65

RVEDV-index, ml/m2

82 ± 13

74 ±8

0.03

RVESV-index, ml/m2

34 ± 9

31 ± 6

0.21

RVSV-index, ml/m2

44 (40-45)

48 (45-49)

0.02

SD = standard deviation, IQR = interquartile range, LV = left ventricle, EF = ejection fraction, EDV = end-diastolic volume, ESV = end-systolic volume, SV = stroke volume, PFR = peak filling rate, RV = right ventricle

Table 3. Cardiac MRI findings in early and chronic RA

Variable

Early RA

Mean (±SD)

Median (IQR)

Chronic RA

Mean (±SD)

Median (IQR)

 p-value

LV EF %

57 (56-58)

60 (59-61)

0.05

LV EDV-index ml/m2

83±11

81±13

0.56

LV ESV-index ml/m2

35±7

33±6

0.13

LV SV-index; ml

48±6

46±14

0.96

LV PFR/EDV; 1/s

3.04±1.67

3.21±0.88

0.61

LV mass-index; g/m2

51±8

52±8

0.86

RV EF %

57±5

61±6

0.008

RV EDV-index ml/m2

84±12

79±13

0.16

RV ESV-index ml/m2

37±8

32±8

0.02

RV SV-index ml/m2

47±5

48±7

0.49

Conclusion:

Patients with active RA show myocardial abnormality on cardiac MRI: prolonged myocardial T1 relaxation times suggesting diffuse inflammation or fibrosis and LGE indicating local myocardial scars. RA patients also had impairments of LV and RV systolic and diastolic functions. Inflammatory activity observed in patients with early RA with lower systolic ventricular functions compared to patients with chronic RA can reflect systemic inflammation.


Disclosure: M. Holmström, None; R. Koivuniemi, None; T. Tiippana-Kinnunen, None; A. Kuuliala, None; M. Leirisalo-Repo, None; S. Kivistö, None.

To cite this abstract in AMA style:

Holmström M, Koivuniemi R, Tiippana-Kinnunen T, Kuuliala A, Leirisalo-Repo M, Kivistö S. Cardiac Magnetic Resonance Imaging Reveals Myocardial Damage in Patients with Active Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/cardiac-magnetic-resonance-imaging-reveals-myocardial-damage-in-patients-with-active-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cardiac-magnetic-resonance-imaging-reveals-myocardial-damage-in-patients-with-active-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology